Multimodality imaging can shift the clinical approach and prognosis of a patient: from heart failure and angina to cardiac amyloidosis
AL (light chain) amyloidosis is a life threatening disease. Untreated patients with involvement of the heart, a condition known as cardiac amyloidosis (CA), tend to have the most rapid disease progression and worst prognosis. Therefore, it is essential to early recognize the signs of symptoms of CA,...
Saved in:
Main Authors: | Alexandra Maria Chitroceanu (Author), Alina Ioana Nicula (Author), Roxana Cristina Rimbas (Author), Mihaela Andreescu (Author), Cristina Popp (Author), Claudiu Stoicescu (Author), Dragos Vinereanu (Author) |
---|---|
Format: | Book |
Published: |
Sciendo,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiac Amyloidosis - An Underdiagnosed Cause of Heart Failure with Preserved Ejection Fraction - Updated Diagnosis and Treatment Options
by: Roxana Cristina RIMBAS, et al.
Published: (2021) -
Functional assessment in left ventricular non-compaction cardiomyopathy in multimodality imaging era might improve the definition
by: Ionela Simona Visoiu, et al.
Published: (2021) -
Multimodality diagnosis of cardiac involvement in COVID-19 patients
by: Anca Balinisteanu, et al.
Published: (2021) -
Status and Future Directions of Therapeutics and Prognosis of Cardiac Amyloidosis
by: Zhang W, et al.
Published: (2023) -
Third Re-Do Surgery in a Young Woman with Massive Early Double-Valve Prosthesis and Thromboembolic Stroke
by: Andreea-Antonia NICA, et al.
Published: (2021)